Levobupivacaine vs Ropivacaine for Epidural Labor Analgesia and Maternal and Fetal outcome

A Comparative Study Between Levobupivacaine and Ropivacaine for Epidural labour Analgesia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067125

Enrollment

100

Registered

2024-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery Health Condition 2: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Inj. Levobupivacaine administered as a local anesthetic agent for epidural labor analgesia: This intervention will be done on patients undergoing epidural labour analgesia for a period

Eligibility

Inclusion criteria

Inclusion criteria: Asa Grade 1 & 2 Primigravidae With Singleton Uncomplicated Pregnancy Asa Grade 1 & 2 All Patients Willing To Give Informed Written Consent

Exclusion criteria

Exclusion criteria: Asa Class 3 Or Higher High Risk Complicated Pregnancy Contraindication Of Neuraxial Block Patient With Bleeding Disorder Patients With Psychiatric Illness

Design outcomes

Primary

Measure	Time frame
In Epidural labor Analgesia, levobupivacaine has demonstrated superior efficacy compared to ropivacaine.Timepoint: 2 YEARS	—

Secondary

Measure	Time frame
APPRAISE HAEMODYNAMIC DURING LABOUR ASSESS THE MATERNAL AND FOETAL OUTCOME Timepoint: 2 YEARS	—

Countries

India

Contacts

Public ContactShafaque Maqusood

Datta Meghe Institute of Medical Science and research

drvivekchakole@rediffmail.com7583836564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026